Our Consortium

The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) is a network of eight centers across the United States and Canada leveraging expertise across multiple fields and working together to better understand rare and genetic conditions leading to impairments in lung defenses and suppurative respiratory disorders. The GDMCC focuses on disorders such as primary ciliary dyskinesia, cystic fibrosis, primary immunodeficiencies, and idiopathic bronchiectasis. Ultimately, we hope to better define the clinical pathogenesis of these important airway diseases, improve and expand diagnostic testing, and develop new and effective treatments.